These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 10216133

  • 1. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GM, Meijer DK, Poelstra K.
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [Abstract] [Full Text] [Related]

  • 2. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE, Poelstra K, Scherphof GL, Meijer DK, van Loenen-Weemaes AM, Reker-Smit C, Morselt HW, Zwiers P, Kamps JA.
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
    Beljaars L, Olinga P, Molema G, de Bleser P, Geerts A, Groothuis GM, Meijer DK, Poelstra K.
    Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
    [Abstract] [Full Text] [Related]

  • 4. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.
    Greupink R, Bakker HI, Bouma W, Reker-Smit C, Meijer DK, Beljaars L, Poelstra K.
    J Pharmacol Exp Ther; 2006 May; 317(2):514-21. PubMed ID: 16439617
    [Abstract] [Full Text] [Related]

  • 5. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
    Adrian JE, Poelstra K, Scherphof GL, Molema G, Meijer DK, Reker-Smit C, Morselt HW, Kamps JA.
    J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
    [Abstract] [Full Text] [Related]

  • 6. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T, Beljaars L, van de Bovenkamp M, Temming K, van Loenen AM, Reker-Smit C, Meijer DK, Lacombe M, Opdam F, Kéri G, Orfi L, Poelstra K, Kok RJ.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [Abstract] [Full Text] [Related]

  • 7. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM, Zhang QS, Lee NP, Wo JY, Leung PP, Liu LX, Hu MY, Cheung KF, Hui CK, Lau GK, Fan ST.
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [Abstract] [Full Text] [Related]

  • 8. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
    van Beuge MM, Prakash J, Lacombe M, Gosens R, Post E, Reker-Smit C, Beljaars L, Poelstra K.
    J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
    [Abstract] [Full Text] [Related]

  • 9. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R, Prakash J, de Ruijter M, Beljaars L, Poelstra K.
    Mol Pharm; 2011 Oct 03; 8(5):1899-909. PubMed ID: 21800888
    [Abstract] [Full Text] [Related]

  • 10. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
    Hagens WI, Mattos A, Greupink R, de Jager-Krikken A, Reker-Smit C, van Loenen-Weemaes A, Gouw IA, Poelstra K, Beljaars L.
    Pharm Res; 2007 Mar 03; 24(3):566-74. PubMed ID: 17245650
    [Abstract] [Full Text] [Related]

  • 11. Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.
    Li FQ, Su H, Chen X, Qin XJ, Liu JY, Zhu QG, Hu JH.
    J Pharm Pharmacol; 2009 Sep 03; 61(9):1155-61. PubMed ID: 19703364
    [Abstract] [Full Text] [Related]

  • 12. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
    Adrian JE, Kamps JA, Scherphof GL, Meijer DK, van Loenen-Weemaes AM, Reker-Smit C, Terpstra P, Poelstra K.
    Biochim Biophys Acta; 2007 Jun 03; 1768(6):1430-9. PubMed ID: 17493581
    [Abstract] [Full Text] [Related]

  • 13. Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine.
    Rachmawati H, Reker-Smit C, Lub-de Hooge MN, van Loenen-Weemaes A, Poelstra K, Beljaars L.
    Drug Metab Dispos; 2007 May 03; 35(5):814-21. PubMed ID: 17312017
    [Abstract] [Full Text] [Related]

  • 14. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.
    Greupink R, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Kok RJ, Meijer DK, Beljaars L, Poelstra K.
    J Hepatol; 2005 Nov 03; 43(5):884-92. PubMed ID: 16083988
    [Abstract] [Full Text] [Related]

  • 15. Disease-induced drug targeting using novel peptide-ligand albumins.
    Meijer DK, Beljaars L, Molema G, Poelstra K.
    J Control Release; 2001 May 14; 72(1-3):157-64. PubMed ID: 11389994
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated rats.
    Greupink R, Reker-Smit C, Proost JH, van Loenen Weemaes AM, de Hooge M, Poelstra K, Beljaars L.
    Biochem Pharmacol; 2007 May 01; 73(9):1455-62. PubMed ID: 17239825
    [Abstract] [Full Text] [Related]

  • 17. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Patel G, Kher G, Misra A.
    J Drug Target; 2012 Feb 01; 20(2):155-65. PubMed ID: 21913877
    [Abstract] [Full Text] [Related]

  • 18. [Targeting glycyrrhetinic acid to hepatic stellate cells in treating rat liver fibrosis].
    Zhang QS, Luk JM, Zhang J, Tian GY.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep 01; 13(9):664-7. PubMed ID: 16174454
    [Abstract] [Full Text] [Related]

  • 19. Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells.
    Ye Z, Cheng K, Guntaka RV, Mahato RI.
    Biochemistry; 2005 Mar 22; 44(11):4466-76. PubMed ID: 15766277
    [Abstract] [Full Text] [Related]

  • 20. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
    Stehle G, Wunder A, Schrenk HH, Hartung G, Heene DL, Sinn H.
    Anticancer Drugs; 1999 Sep 22; 10(8):785-90. PubMed ID: 10573211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.